Impact News +++ SoFi Technologies drops 6%, prices $1.5 billion stock offering (SeekingAlpha) +++ SOFI TECHNOLOGIES Aktie -6,21%

UNIQURE Aktie

>UNIQURE Aktienkurs

19.03 EUR -2.6% (Tradegate)

Ask: 19.04 EUR / 257 Stück

Bid: 18.755 EUR / 261 Stück

Tagesumsatz: 50 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

UNIQURE Aktie über LYNX handeln

Intraday

1 Jahr

>UNIQURE Performance

1 Woche: -16,6%

1 Monat: -27,4%

3 Monate: +33,8%

6 Monate: +49,4%

1 Jahr: +232,8%

laufendes Jahr: +19,4%

>UNIQURE Aktie

Name:

UNIQURE N.V. EO -,05

Land:

Niederlande

Sektor:

Gesundheit

ISIN/ Wkn:

NL0010696654 / A1XDTV

Symbol/ Ticker:

UQ1 (Frankfurt) / QURE (NASDAQ)

Kürzel:

FRA:UQ1, ETR:UQ1, UQ1:GR, NASDAQ:QURE

Index:

Webseite:

https://www.uniqure.com/

Profil:

uniQure N.V. is a biopharmaceutical company specia..
>Volltext..

Marktkapitalisierung:

1345.15 Mio. EUR

Unternehmenswert:

1206.6 Mio. EUR

Umsatz:

13.5 Mio. EUR

EBITDA:

-151.61 Mio. EUR

Nettogewinn:

-201.51 Mio. EUR

Gewinn je Aktie:

-3.76 EUR

Schulden:

455.62 Mio. EUR

Liquide Mittel:

511.66 Mio. EUR

Operativer Cashflow:

-131.94 Mio. EUR

Bargeldquote:

6.9

Umsatzwachstum:

-47.72%

Gewinnwachstum:

6.84%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.034.398 USD.

Suchwörter:

UNIQURE

Letzte Datenerhebung:

05.12.25

>UNIQURE Kennzahlen

Aktien/ Unternehmen:

Aktien: 61.6 Mio. St.

Frei handelbar: 92.15%

Leerverk. Aktien: 13.47%

Rückkaufquote: -26.08%

Mitarbeiter: 209

Umsatz/Mitarb.: 0.11 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 177.34%

Bewertung:

KGV: -

KGV lG: -

KUV: 98.41

KBV: 5.56

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -14.37%

Gewinnmarge: -1492.9%

Operative Marge: -1225.66%

Managementeffizenz:

Gesamtkaprendite: -30.65%

Eigenkaprendite: -165.27%

>UNIQURE Peer Group

Es sind 19 Aktien bekannt.

>UNIQURE Chart & Kurs - NASDAQ

>UNIQURE News

04.12.25 - 22:51	QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm (PR Newswire)
	RADNOR, Pa., Dec. 4, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) ("uniQure"). On November 3, 2025, uniQure issued......

04.12.25 - 15:06	uniQure stock falls after FDA′s notes on pre application of AMT-130 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.12.25 - 14:18	uniQure-Aktie stürzt ab: FDA-Feedback deutet auf unzureichende Daten für Huntington-Therapie hin (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

04.12.25 - 13:09

uniQure Provides Regulatory Update on AMT-130 for Huntington′s Disease (GlobeNewswire EN)

LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the company received final meeting minutes from the U.S. Food and Drug Administration (FDA) regarding a pre-Biologics License Application (BLA) meeting held on October 29, 2025 to discuss the application for AMT-130, an investigational gene therapy for Huntington's disease (HD). ...

28.11.25 - 17:48	QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm (PR Newswire)
	RADNOR, Pa., Nov. 28, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) ("uniQure"). On November 3, 2025, uniQure......

22.11.25 - 17:42	QURE Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm (PR Newswire)
	RADNOR, Pa., Nov. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) ("uniQure"). On November 3, 2025, uniQure......

20.11.25 - 16:06	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE (PR Newswire)
	NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

14.11.25 - 10:18	uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE (PR Newswire)
	LOS ANGELES, Nov. 14, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or "the Company") (NASDAQ: QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the......

11.11.25 - 10:42	QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm (PR Newswire)
	LOS ANGELES, Nov. 11, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or "the Company") (NASDAQ: QURE) for violations of the securities laws. The......

11.11.25 - 10:24	uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE (PR Newswire)
	LOS ANGELES, Nov. 11, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or "the Company") (NASDAQ: QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the......

11.11.25 - 02:33	QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm (PR Newswire)
	RADNOR, Pa., Nov. 10, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) ("uniQure"). On November 3, 2025, uniQure......

11.11.25 - 02:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Uniqure im Wert von 856881 USD (Insiderkauf)
	Gut, Robert - Aufsichtsrat - Tag der Transaktion: 2025-11-06...

10.11.25 - 17:15	UniQure outlines urgent FDA engagement for AMT-130 as BLA timing turns uncertain (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.11.25 - 16:24	uniQure (QURE) Q3 2025 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

10.11.25 - 16:00	uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
	uniQure (QURE) delivered earnings and revenue surprises of -62.35% and -46.62%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

10.11.25 - 13:12	uniQure GAAP EPS of -$1.38 misses by $0.50, revenue of $3.7M misses by $1.44M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.11.25 - 13:09	uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire EN)
	~ Announced pivotal topline data from Phase I/II study of AMT-130 in Huntington's disease met its primary and key secondary endpoints, demonstrating statistically significant slowing of disease progression at 36 months and supportive trends across key clinical and biomarker endpoints ~...

07.11.25 - 19:30	uniQure Q3 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.11.25 - 05:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Uniqure im Wert von 1177517 USD (Insiderkauf)
	Kaye, Jack - Aufsichtsrat - Tag der Transaktion: 2025-11-04...

06.11.25 - 13:06	uniQure to Announce Third Quarter 2025 Financial Results (GlobeNewswire EN)
	~ uniQure to host earnings call on Monday, November 10, 2025 at 8:30 a.m. ET ~ ~ uniQure to host earnings call on Monday, November 10, 2025 at 8:30 a.m. ET ~...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram